Puberty blockers

Conservative MPs are calling for a debate on the use of puberty blockers in treating young people with gender dysphoria. The debate will air concerns about the safety, evidence base, and appropriate regulation of these medications, which pause the onset of puberty. This touches on a live policy question: whether current NHS guidance on puberty blockers is sufficiently cautious, and what role Parliament should play in setting clinical standards.

Puberty blockers are prescribed to transgender and non-binary young people on NHS services. This Opposition Day debate signals Conservative pressure on Labour to tighten restrictions or commission further safety reviews. The outcome could influence NHS clinical guidance, medical training, and access to treatment for a sensitive patient cohort.